文献速递妇产影像US

胎儿医学基金会竞争风险模型在西班牙人群中孕中期预测小于胎龄儿的的外部验证

External validation of Fetal Medicine Foundation competing-risks model for midgestation prediction of small-for-gestational-age neonates in Spanish population.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

这项单中心前瞻性队列研究纳入25 484例单胎孕妇,在孕19+0至23+6周超声检查中应用胎儿医学基金会竞争风险模型(结合母体因素、超声估计胎儿体重和子宫动脉搏动指数)预测小于胎龄儿。在10%假阳性率下,对分娩<32周、<37周和≥37周的SGA<10百分位的检出率分别为69.6%、38.7%和31.7%;模型校准满意,在西班牙人群中表现良好。

要点

  • 孕中期联合母体因素、EFW和UtA-PI预测早产SGA<32周检出率最高(10%FPR下69.6%)。
  • 对足月SGA≥37周的检出率较低(10%FPR下31.7%),与FMF原研究相似或更低。
  • 模型校准满意,但验证队列构成与FMF开发队列显著不同。

核心结论

  • FMF新竞争风险模型在大型西班牙独立人群中孕中期预测SGA表现良好。

研究设计与样本

  • 单中心前瞻性队列研究,纳入25 484例单胎妊娠孕妇,于孕19+0至23+6周行常规超声检查。

诊断标准与关键数值

  • 10%假阳性率下,母体因素、EFW和UtA-PI联合对SGA<10百分位且分娩<32周的检出率为69.6%,对分娩<37周为38.7%,对分娩≥37周为31.7%。
  • 10%假阳性率下,对SGA<3百分位且分娩<32周、<37周、≥37周的检出率分别为75.7%、48.2%、38.1%。
  • 15%假阳性率下,对SGA<10百分位且分娩<32周、<37周、≥37周的检出率分别为77.4%、50.0%、41.5%。

临床应用与阅片要点

  • 孕中期可联合母体因素、EFW和UtA-PI应用FMF竞争风险模型评估SGA风险。
  • 模型对早产SGA<32周预测效能较高,对足月SGA预测效能相对较低。
  • 验证队列检出率与FMF队列中初产妇和高加索女性亚组相似。

局限性

  • 验证队列构成与FMF模型开发队列存在显著差异。
  • 对分娩<37周和≥37周的SGA检出率低于FMF原研究报道值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To examine the external validity of the new Fetal Medicine Foundation (FMF) competing-risks model for prediction in midgestation of small-for-gestational-age (SGA) neonates.

METHODS: This was a single-center prospective cohort study of 25 484 women with a singleton pregnancy undergoing routine ultrasound examination at 19 + 0 to 23 + 6 weeks' gestation. The FMF competing-risks model for the prediction of SGA combining maternal factors and midgestation estimated fetal weight by ultrasound scan (EFW) and uterine artery pulsatility index (UtA-PI) was used to calculate risks for different cut-offs of birth-weight percentile and gestational age at delivery. The predictive performance was evaluated in terms of discrimination and calibration.

RESULTS: The validation cohort was significantly different in composition compared with the FMF cohort in which the model was developed. In the validation cohort, at a 10% false-positive rate (FPR), maternal factors, EFW and UtA-PI yielded detection rates of 69.6%, 38.7% and 31.7% for SGA < 10th percentile with delivery at < 32, < 37 and ≥ 37 weeks' gestation, respectively. The respective values for SGA < 3rd percentile were 75.7%, 48.2% and 38.1%. Detection rates in the validation cohort were similar to those reported in the FMF study for SGA with delivery at < 32 weeks but lower for SGA with delivery at < 37 and ≥ 37 weeks. Predictive performance in the validation cohort was similar to that reported in a subgroup of the FMF cohort consisting of nulliparous and Caucasian women. Detection rates in the validation cohort at a 15% FPR were 77.4%, 50.0% and 41.5% for SGA < 10th percentile with delivery at < 32, < 37 and ≥ 37 weeks, respectively, which were similar to the respective values reported in the FMF study at a 10% FPR. The model had satisfactory calibration.

CONCLUSION: The new competing-risks model for midgestation prediction of SGA developed by the FMF performs well in a large independent Spanish population. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Albaiges G, Papastefanou I, Rodriguez I, et al. External validation of Fetal Medicine Foundation competing-risks model for midgestation prediction of small-for-gestational-age neonates in Spanish population. Ultrasound Obstet Gynecol. 2023. PMID: 36971008. doi:10.1002/uog.26210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。